Target intelligence / Profile preview

Cadherin-12 (CDH12)

Target
CDH12
Molecular classification
Type II classical cadherin, Cadherin superfamily, Cell adhesion molecule
01

Overview

Cadherin-12 (CDH12) is a type II classical cadherin belonging to the cadherin superfamily of calcium-dependent cell-cell adhesion proteins. It comprises a large extracellular domain, a transmembrane segment, and a conserved cytoplasmic tail. CDH12 is predominantly expressed in the brain and is implicated in neuronal development, neurite outgrowth, and synaptogenesis. It mediates homophilic cell interactions, contributing to tissue morphogenesis and the organization of neuronal circuits. CDH12 has emerging roles in various cancers and neuropsychiatric disorders. Experimental studies demonstrate that CDH12 affects neurite extension through the cAMP/PKA pathway and signaling molecules such as Rac1 and Cdc42. Therapeutic modulation or use as a biomarker remains primarily investigational.

Other names
Cadherin-12CDH12BR-cadherinBrain cadherinNeural type cadherin 2N-cadherin 2CDHBBr-cadherinbrain-cadherinneuronal cadherin 2cadherin, neural type, 2
02

Mechanism of action

Agonists/inhibitors modulate neurite outgrowth via cAMP/PKA pathway, affecting Rac1/Cdc42 signaling

03

Biological functions

Calcium-dependent cell-cell adhesionNeuronal developmentSynaptogenesisNeurite outgrowthCell proliferationCell differentiationApoptosis
04

Disease associations

Cancer (e.g., salivary adenoid cystic carcinoma, colorectal cancer, non-small cell lung cancer)Neuropsychiatric disorders (e.g., Autism Spectrum Disorder)Craniofacial-Deafness-Hand Syndrome
05

Safety considerations

Modulation of CDH12 may affect neural circuit formation and cell adhesion, possibly influencing neurodevelopment or tumor progression
06

Interacting drugs

8-bromo-cAMP sodium salt (PKA agonist, experimental use)

1 more in the full profile.

07

Biomarkers

Expression of CDH12 as a potential biomarker for cancer prognosis and neurodevelopmental conditions (experimental)

Beyond the preview

Go deeper on Cadherin-12 (CDH12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cadherin-12 (CDH12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call